Antiva Biosciences has filed a notice of an exempt offering of securities to raise $52,999,990.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Antiva Biosciences is raising $52,999,990.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Kristine Ball played a key role…